Business
Viveve(R) Announces Resignation of Brigitte Smith From Company Board of Directors
Viveve(R) Announces Resignation of Brigitte Smith From Company Board of Directors.
About this update from Viveve Medical, Inc.
[{"type":"text","content":"\nViveve(R) Announces Resignation of Brigitte Smith From Company Board of Directors\n\nViveve(R) Announces Resignation of Brigitte Smith From Company Board of Directors\n\nSUNNYVALE, CA--(Marketwired - September 15, 2016) - Viveve Medical, Inc. (\"Viveve\") (NASDAQ: VIVE), a medical technology company focused on women's health, today announced that Brigitte Smith has resigned as a director of Viveve's Board of Directors, including from her positions as Chairman of the Board and member of the Compensation Committee and Governance and Nominating Committee. Her resignation will be effective September 30, 2016. Ms. Smith joined the company in 2007 as a member of the Board of Directors of Viveve, Inc., the company's operating subsidiary, representing GBS Venture Partners Pty Ltd., one of the company's original venture capital investors.\"We thank Brigitte Smith for her expert counsel and guidance during her long tenure as a valued member of the board, which has played an important role in helping us advance our business strategy and our global commercial plans for the Viveve System,\" said Patricia Scheller, chief executive officer of Viveve. \"We will miss her dedicated support for the Company and wish her well with her future endeavors.\"\"I am proud to have been a part of the organization and to have worked with the outstanding management team and my fellow board members at Viveve to accomplish many significant milestones over the years,\" said Ms. Smith. \"I am sure that the company will continue to build on these strengths. My departure is not related to any developments at Viveve and I continue to have great confidence in the company and its prospects for a highly successful future.\"About ViveveViveve Medical, Inc. is a women's health company passionately committed to advancing new solutions to improve women's overall well-being and quality of life. The company's lead product, the internationally patented Viveve System, is a non-surgical, non-ablative medical device that remodels collagen and restores tissue with only one treatment session. The Viveve System treats the condition of vaginal laxity that can result in decreased physical sensation and sexual satisfaction. Physician surveys indicate that vaginal laxity is the number one post-delivery physical change for women, being more prevalent than weight gain, urinary incontin...